- Report
- August 2023
- 70 Pages
Europe
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 180 Pages
Global
From €4742EUR$4,969USD£3,973GBP
- Report
- November 2023
- 160 Pages
Global
From €3435EUR$3,599USD£2,878GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3692EUR$3,869USD£3,094GBP
- Report
- October 2023
- 177 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 70 Pages
Brazil
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Europe
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Asia Pacific
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
North America
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
United States
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Italy
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
India
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Vietnam
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Spain
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Iran
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Australia
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Brazil
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 150 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
China
From €4533EUR$4,750USD£3,798GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more